The repositioning of the company’s Chirositol ingredient, which contains the active constituent D-Chiro-Inositol and has been the subject of 30 published scientific studies, comes in response to data that women are the primary buyer of products containing the ingredient.
“We have experienced outstanding success with supplements containing Chirositol,” said Matt Phillips, president and COO of Cyvex. “We understand that women are the primary buyer of these products and are now focusing on expanding sales by securing additional supplement manufacturers to license the ingredient for major new product launches."